Bethyl Laboratories

Ushering in the Second Wave of Checkpoint Blockade Therapies

Catalog #article062
Ushering in the Second Wave of Checkpoint Blockade Therapies, no image available

Product Description

Immune checkpoint blockade has emerged over the past decade as a useful therapeutic tool against many types of tumors. Checkpoint blockade therapies take advantage of the fact that many tumors are infiltrated by immune cells, but those cells are unable to effectively kill the tumor due to inhibitory signals that limit their function. By reversing inhibitory signals that block T cell functionality, checkpoint blockade therapy reactivates immune cells already in a tumor and allows them to resume their effector function1.
Using this product in your research?Published applications help other scientists evaluate reagents and accelerate assay development.Upload Your Publication

Services

Resources